Daily Oral PCSK9 Inhibitor Encouraging in Phase 1 Trials
What if the cholesterol-crushing efficacy of current PCSK9 inhibitors came in a pill instead of a syringe? That's one possibility for a Merck agent in the earliest stages of human trials.
Source: medscape.com